Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,339 public trials 1,980 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer

NCT03289195

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer

NCT01203839

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Follow-up Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Follow-up Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Follow-up Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk (Follow-up Only) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)

NCT02393794

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • University of Kansas Cancer Center - Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center - West Kansas City, Kansas, United States
  • University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States
  • University of Kansas Cancer Center - Westwood Westwood, Kansas, United States
View Trial Details
Active, Not Recruiting

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

NCT03734029

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Ironwood Cancer & Research Centers - Chandler II Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cancer Treatment Centers of America at Western Regional Medical Center Goodyear, Arizona, United States
  • UCLA School of Medicine Los Angeles, California, United States
View all 208 locations
View Trial Details
Active, Not Recruiting

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy

NCT05840211

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Unresectable Metastatic Breast Cancer, +5 more
Locations
  • Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Los Angeles Hematology Oncology Medical Group Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 288 locations
View Trial Details
Active, Not Recruiting

Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer

NCT02826434

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Massachusetts general Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +33 more
Locations
  • Ellison Institute Los Angeles, California, United States
  • Smilow Cancer Hospital at Yale - New Haven New Haven, Connecticut, United States
  • Yale-New Haven Hospital-Yale Cancer Center New Haven, Connecticut, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
View all 38 locations
View Trial Details

Related conditions